The LabPS score: Inexpensive, Fast, and Site-agnostic Survival Prediction.
Carsten NiederEllinor C HauklandBård MannsåkerAstrid DalhaugPublished in: American journal of clinical oncology (2023)
If busy clinicians prefer a general prognostic model rather than a panel of separate diagnosis-specific/target-specific scores, they may consider validating the LabPS score in their own practice. In resource-constrained settings, inexpensive standard blood tests may be preferable over imaging-derived prognostic information. Just like other available scores, the LabPS cannot identify all patients with very short survival.